http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105816468-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 |
| filingDate | 2015-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105816468-B |
| titleOfInvention | A kind of preparation and preparation method for reducing Compound New Nomin side effect |
| abstract | The present invention relates to a kind of preparation and preparation method for reducing Compound New Nomin side effect, important component includes sulfamethoxazole (SMZ), trimethoprim (TMP), beta cyclodextrin, sodium bicarbonate, starch, magnesium stearate.The mass percent of each component is：3.6% 13.5% sulfamethoxazoles (SMZ), 0.7% 4.5% trimethoprim (TMP), 3.6% 13.5% sodium bicarbonates, 67% 69% beta cyclodextrins, 0.4% 1.3% starch, 0.2% 0.8% 10% starch slurry, 0.2% 0.8% dried starch, 0.03% 0.1% magnesium stearates, this complex tablet have the advantages that reduce Compound New Nomin to kidney damage and medication it is convenient. |
| priorityDate | 2015-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 59.